Abstract
Three and a Half Years of Multi-Allergen Subcutaneous Immunotherapy Is Associated with a 50% Reduction in Asthma Symptom Scores
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
